Stat4 suppresses the proliferation of connective tissue-type mast cells

Laboratory Investigation

Volumn 88, Issue 8, 2008, Pages 856-864

  Kataoka, Tatsuki R ^a,b,c   Nishizawa, Yasuko ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

IL 6; Mast cell; Stat3; Stat4

Indexed keywords

CYCLIN D3; INTERLEUKIN 6; KITL PROTEIN; PROTEIN; STAT4 PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BAGG ALBINO MOUSE; CELL COUNT; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOMEOSTASIS; MAST CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN; UPREGULATION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLINS; INTERLEUKIN-6; MAST CELLS; MICE; MICE, INBRED BALB C; SKIN; STAT3 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; STEM CELL FACTOR;

EID: 48749096517     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.51     Document Type: Article

References (33)

1. Maurer M, Theoharides T, Granstein RD, et al. What is the physiological function of mast cells? Exp Dermatol 2003;12:886-910.
2. v mice and their increase by bone marrow transplantation. Blood 1978;52:447-452.
3. v mice. J Exp Med 1985;162:1025-1043.
4. Kataoka TR, Komazawa N, Morii E, et al. Involvement of connective tissue-type mast cells in Th1 immune responses via Stat4 expression. Blood 2005;105:1016-1020.
5. Nabel G, Galli SJ, Dvorak AM, et al. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature 1981;291:332-334.
6. Galli SJ, Dvorak AM, Marcum JA, et al. Mast cell clones: a model for the analysis of cellular maturation. J Cell Biol 1982;95:435-444.
7. Tsai M, Takeishi T, Thompson H, et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 1991;88:6382-6386.
8. Levi-Schaffer F, Austin KF, Gravallese PM, et al. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc Natl Acad Sci USA 1986;83:6485-6488.
9. Fumo G, Akin C, Metcalfe DD, et al. 17-Allylamino-17- demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood 2004;103:1078-1084.
10. Shelburne CP, McCoy ME, Piekorz R, et al. Stat5 expression is critical for mast cell development and survival. Blood 2003;102:1290-1297.
11. Sherman MA, Secor VH, Lee SK, et al. STAT6-independent production of IL-4 by mast cells. Eur J Immunol 1999;29:1235-1239.
12. Ryan JJ, DeSimone S, Klisch G, et al. IL-4 inhibits mouse mast cell FcεRI expression through a STAT6-dependent mechanism. J Immunol 1998;161:6915-6923.
13. Mirmonsef P, Shelburne CP, Yeatman II F, et al. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3′-kinase. J Immunol 1999;163:2530-2539.
14. Suzuki K, Nakajima H, Ikeda K, et al. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-α production in mast cells. J Exp Med 2003;198:1717-1727.
15. Kaplan MH, Sun Y-L, Hoey T, et al. Impaired IL-12 responses and enhanced development of Th1 cells in Stat4-deficient mice. Nature 1996;382:174-177.
16. Leong P, Andrews GA, Johnson DE, et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci USA 2003;100:4138-4143.
17. Morii E, Ito A, Jippo T, et al. Number of mast cells in the peritoneal cavity of mice. Am J Pathol 2004;165:491-499.
18. Chen H, Isozaki K, Kinoshita K, et al. Imatinib inhibits various types of activating mutant KIT found in gastrointestinal stromal tumors. Int J Cancer 2003;105:130-135.
19. Porstmann T, Ternynck T, Avrameas S. Quantitation of 5-bromo-2- deoxyuridine incorporation into DNA: an enzyme immunoassay for the assessment of the lymphoid cell proliferative response. J Immunol Methods 1985;82:169-179.
20. 816 mutant c-Kit-mediated cytokine-independent survival and proliferation in human leukemia cells. Blood 2001;97:3559-3567.
21. Corbin AS, Griswold IJ, La Rosee P, et al. Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970. Blood 2004;104:3754-3757.
22. Casteran N, De Sepulveda P, Beslu N, et al. Signal transduction by several KIT juxtamembrane domain mutations. Oncogene 2003;22:4710-4722.
23. Kip1 in proliferation of mast cells induced by interleukin-3 but not stem cell factor. Exp Hematol 2001;29:803-811.
24. 1 to S cell-cycle transition. EMBO J 1998;17:6670-6677.
25. Gagari E, Tsai M, Lantz CS, et al. Differential release of mast cell interleukin-6 via c-kit. Blood 1997;89:2654-2663.
26. Kamiura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003;149:1-38.
27. Morii E, Oboki K, Ishihara K, et al. Roles of MITF for development of mast cells in mice: effects on both precursors and tissue environments. Blood 2004;104:1656-1661.
28. Broxmeyer HE, Bruns HA, Zhang S, et al. Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M. Immunity 2002;16:815-825.
29. Shivakrupa R, Linnekin D. Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells. Cell Signal 2005;17:103-109.
30. Nishida K, Wang L, Morii E, et al. Requirement of Gab2 for mast cell development and KitL/c-kit signaling. Blood 2002;99:1866-1869.
31. Yu M, Luo J, Yang W, et al. The scaffolding adapter Gab2, via Shp-2, regulates Kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem 2006;281:28615-28626.
32. h with a minimum effect on that of Treg in the steady state. Int Immunol 2007;19:695-702.
33. Kip1. J Immunol 2002;169:714-721.